Cell and Gene Therapy Summit 2023

Simplify the conversation around the advancement of cell and gene products in the market

Under the stewardship of The Economist editors, our inaugural event on cell and gene therapies convenes industry stakeholders to accelerate access to transformative products.

Cell and gene therapies are redefining the treatment of many diseases, giving hope to patients who previously had no therapeutic options. These treatments can be transformative in the battle against cancer, genetic disorders and rare diseases. In the UK, NICE expects to review 30 new cell and gene therapy products by 2023, with the FDA in the US predicting between 15 and 20 new products will be on the market by 2025.

Attendees will learn how healthcare systems and policies need to evolve before these therapies can become mainstream.